224 related articles for article (PubMed ID: 27109038)
21. Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
Lakatos A; Gyurcsik B; Nagy NV; Csendes Z; Wéber E; Fülöp L; Kiss T
Dalton Trans; 2012 Feb; 41(6):1713-26. PubMed ID: 22159144
[TBL] [Abstract][Full Text] [Related]
22. Effects of cyclen and cyclam on zinc(II)- and copper(II)-induced amyloid beta-peptide aggregation and neurotoxicity.
Chen T; Wang X; He Y; Zhang C; Wu Z; Liao K; Wang J; Guo Z
Inorg Chem; 2009 Jul; 48(13):5801-9. PubMed ID: 19496588
[TBL] [Abstract][Full Text] [Related]
23. Brazilin inhibits the Zn
Guo J; Sun W; Liu F
J Inorg Biochem; 2017 Dec; 177():183-189. PubMed ID: 28972932
[TBL] [Abstract][Full Text] [Related]
24. Multifunctionality of Acidulated Serum Albumin on Inhibiting Zn²⁺-Mediated Amyloid β-Protein Fibrillogenesis and Cytotoxicity.
Xie B; Dong X; Wang Y; Sun Y
Langmuir; 2015 Jul; 31(26):7374-80. PubMed ID: 26070334
[TBL] [Abstract][Full Text] [Related]
25. Small bifunctional chelators that do not disaggregate amyloid β fibrils exhibit reduced cellular toxicity.
Sharma AK; Kim J; Prior JT; Hawco NJ; Rath NP; Kim J; Mirica LM
Inorg Chem; 2014 Nov; 53(21):11367-76. PubMed ID: 25333939
[TBL] [Abstract][Full Text] [Related]
26. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
27. Spectroscopic study on the interaction of Aβ42 with di(picolyl)amine derivatives and the toxicity to SH-S5Y5 cells.
Kong MY; Chen QY; Yao L; Wang YB
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():225-8. PubMed ID: 25498817
[TBL] [Abstract][Full Text] [Related]
28. pH-dependence of the specific binding of Cu(II) and Zn(II) ions to the amyloid-β peptide.
Ghalebani L; Wahlström A; Danielsson J; Wärmländer SK; Gräslund A
Biochem Biophys Res Commun; 2012 May; 421(3):554-60. PubMed ID: 22525674
[TBL] [Abstract][Full Text] [Related]
29. Disaggregation ability of different chelating molecules on copper ion-triggered amyloid fibers.
Zhu L; Han Y; He C; Huang X; Wang Y
J Phys Chem B; 2014 Aug; 118(31):9298-305. PubMed ID: 25051063
[TBL] [Abstract][Full Text] [Related]
30. Structures and free energy landscapes of aqueous zinc(II)-bound amyloid-β(1-40) and zinc(II)-bound amyloid-β(1-42) with dynamics.
Wise-Scira O; Xu L; Perry G; Coskuner O
J Biol Inorg Chem; 2012 Aug; 17(6):927-38. PubMed ID: 22674434
[TBL] [Abstract][Full Text] [Related]
31. 8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation.
Gomes LM; Vieira RP; Jones MR; Wang MC; Dyrager C; Souza-Fagundes EM; Da Silva JG; Storr T; Beraldo H
J Inorg Biochem; 2014 Oct; 139():106-16. PubMed ID: 25019963
[TBL] [Abstract][Full Text] [Related]
32. Tau/Aβ chimera peptides: A Thioflavin-T and MALDI-TOF study of Aβ amyloidosis in the presence of Cu(II) or Zn(II) ions and total lipid brain extract (TLBE) vesicles.
Sciacca MFM; Di Natale G; Milardi D; Pappalardo G
Chem Phys Lipids; 2021 Jul; 237():105085. PubMed ID: 33895131
[TBL] [Abstract][Full Text] [Related]
33. Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.
Huang L; Lu C; Sun Y; Mao F; Luo Z; Su T; Jiang H; Shan W; Li X
J Med Chem; 2012 Oct; 55(19):8483-92. PubMed ID: 22978824
[TBL] [Abstract][Full Text] [Related]
34. Zn impacts Cu coordination to amyloid-β, the Alzheimer's peptide, but not the ROS production and the associated cell toxicity.
Alies B; Sasaki I; Proux O; Sayen S; Guillon E; Faller P; Hureau C
Chem Commun (Camb); 2013 Feb; 49(12):1214-6. PubMed ID: 23282470
[TBL] [Abstract][Full Text] [Related]
35. The aggregation of aβ42 induced by nano copper and the antagonistic action of polysaccharides.
Wang W; Zhang G; Zou J
Appl Biochem Biotechnol; 2015 Feb; 175(3):1557-66. PubMed ID: 25410807
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer's disease.
Xie S; Chen J; Li X; Su T; Wang Y; Wang Z; Huang L; Li X
Bioorg Med Chem; 2015 Jul; 23(13):3722-9. PubMed ID: 25934229
[TBL] [Abstract][Full Text] [Related]
37. Zn(II) ions substantially perturb Cu(II) ion coordination in amyloid-β at physiological pH.
Silva KI; Saxena S
J Phys Chem B; 2013 Aug; 117(32):9386-94. PubMed ID: 23841511
[TBL] [Abstract][Full Text] [Related]
38. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
Li X; Wang W; Dong X; Sun Y
J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
[TBL] [Abstract][Full Text] [Related]
39. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
40. Cu(II)-Zn(II) Cross-Modulation in Amyloid-Beta Peptide Binding: An X-ray Absorption Spectroscopy Study.
De Santis E; Minicozzi V; Proux O; Rossi G; Silva KI; Lawless MJ; Stellato F; Saxena S; Morante S
J Phys Chem B; 2015 Dec; 119(52):15813-20. PubMed ID: 26646533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
